NasdaqGS:MEDPLife Sciences
Medpace (MEDP) Stock May Be Below Fair Value On Raised Guidance
Medpace Holdings has delivered a very strong 5 year share price return, yet the current checks suggest the stock now sits in a zone where its intrinsic value estimate looks broadly in line with the market price while traditional earnings multiples lean expensive.
Around 242% total return over the past 5 years points to a stock where expectations have already moved a long way.
Recent strong revenue and earnings momentum can support the current valuation, but any change in growth expectations...